Eastman Kodak Co.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Eastman Kodak Co.
Kodak CEO Jim Continenza is revealing nothing about ongoing investigations, which leave Kodak’s plans to venture into pharmaceuticals – along with a $765m federal loan – uncertain.
Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.
After implementing a major workforce reduction in January, Abbott Laboratories re-organized its diversified company into three units – proprietary pharmaceuticals, durable growth products and innovation-driven devices. Its latest announcement cements that change: Abbott will divide into a diversified medical products company.
The founder of Eyeon Therapeutics thinks that his firm will take giant steps forward in the next six months towards commercializing an over-the-counter nanotechnology-based eye drop for treating dry eye.
- In Vitro Diagnostics